An expert in gout clinical trials questions whether ethical considerations for such trials need updating to emphasize patient ...

The benefits and challenges of returning to academia after a period away ...

What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to ...

Terns Pharmaceuticals has shelved its oral GLP-1 obesity candidate after a phase 2 trial delivered a mix of weight loss and ...

In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...

Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies October 28, 2025 2:00 ...

Q3 2025 Earnings Call October 30, 2025 8:30 AM EDTCompany ParticipantsRalph Giacobbe - Senior Vice President of Investor ...

Polypills for HFrEF are being tested in RCTs, and if they’re approved, experts want to be ready for their rollout and use.

Application based on positive results from Phase 3 PEGASUS study, which demonstrated statistically significant blood phenylalanine (Phe) lowering compared to diet ...

EVERYONE talks about starting weight loss jabs – but what about stopping them? If you’re worried about the food noise roaring ...

Detailed price information for Livanova Plc OR Sh (LIVN-Q) from The Globe and Mail including charting and trades.